Neuromuscular Nondepolarizing Agents
"Neuromuscular Nondepolarizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.
| Descriptor ID |
D003473
|
| MeSH Number(s) |
D27.505.696.663.700.710.575
|
| Concept/Terms |
Neuromuscular Nondepolarizing Agents- Neuromuscular Nondepolarizing Agents
- Agents, Neuromuscular Nondepolarizing
- Nondepolarizing Agents, Neuromuscular
- Curariform Drugs
- Drugs, Curariform
- Nondepolarizing Blockers
- Blockers, Nondepolarizing
- Neuromuscular Blocking Agents, Competitive
- Curare-Like Agents
- Agents, Curare-Like
- Curare Like Agents
- Muscle Relaxants, Non-Depolarizing
- Muscle Relaxants, Non Depolarizing
- Non-Depolarizing Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Nondepolarizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Nondepolarizing Agents".
This graph shows the total number of publications written about "Neuromuscular Nondepolarizing Agents" by people in this website by year, and whether "Neuromuscular Nondepolarizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Nondepolarizing Agents" by people in Profiles.
-
Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival. Anesth Analg. 2017 05; 124(5):1476-1483.
-
Refining the anesthesia management of the face-lift patient: lessons learned from 1089 consecutive face lifts. Plast Reconstr Surg. 2015 Mar; 135(3):723-730.
-
Neuromuscular monitoring and postoperative residual curarization. Br J Anaesth. 2007 Aug; 99(2):297; author reply 297-9.
-
Intraoperative wake-up test in neonatal neurosurgery. Paediatr Anaesth. 2006 Apr; 16(4):451-3.
-
Myocardial performance index with sevoflurane-pancuronium versus fentanyl-midazolam-pancuronium in infants with a functional single ventricle. Anesthesiology. 2004 Dec; 101(6):1298-305.
-
Recovery of neuromuscular function after cardiac surgery: pancuronium versus rocuronium. Anesth Analg. 2003 May; 96(5):1301-1307.
-
Heterotopic ossification in critical illness and cancer: a report of 2 cases. Arch Phys Med Rehabil. 2002 Jun; 83(6):855-9.
-
Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient. Anesthesiology. 2002 Mar; 96(3):600-6.
-
Pancuronium added to intravenous regional anesthesia: systemic weakness after prolonged tourniquet inflation time. Can J Anaesth. 2001 Jan; 48(1):102.
-
The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg. 1999 Apr; 88(4):746-8.